H.C. Wainwright Reiterates Buy Rating on Regenxbio Inc. (RGNX)

June 23, 2026 6:51 AM

H.C. Wainwright analyst Yi Chen reiterated a Buy rating and $26.00 price target on Regenxbio Inc. (NASDAQ: RGNX).The analyst commented ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found